The BCL-2 family member BOK promotes KRAS-driven lung cancer progression in a p53-dependent manner.
Meinhardt AL, Munkhbaatar E, Höckendorf U, Dietzen M, Dechant M, Anton M, Jacob A, Steiger K, Weichert W, Brcic L, McGranahan N, Branca C, Kaufmann T, Dengler MA, Jost PJ.
Meinhardt AL, et al. Among authors: dengler ma.
Oncogene. 2022 Feb;41(9):1376-1382. doi: 10.1038/s41388-021-02161-1. Epub 2022 Jan 29.
Oncogene. 2022.
PMID: 35091677
Free PMC article.